This inventor holds 1 USPTO granted patent. Top assignee: Globomax LLC. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of Leonid V Gibiansky
Introduction
Leonid V Gibiansky is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of biological modeling, particularly through his innovative patent that enhances the understanding of drug absorption and release.
Latest Patents
Gibiansky holds a patent for a "Tool for in vitro-in vivo correlation." This invention provides a biological modeling system and method for enhanced computer-aided analysis of biological response data. It synthesizes information from both immediate and extended release in vivo data and in vitro data. The model developed from this information allows for a two-stage approach to modeling, which includes deconvolution to determine the percentage of drug absorbed and correlating in vivo data with in vitro dissolution profiles. This correlation establishes a point-to-point relationship between in vitro dissolution and in vivo drug input rates.
Career Highlights
Gibiansky's career is marked by his work at Globomax LLC, where he has applied his expertise in biological modeling. His innovative approach has led to advancements in understanding drug absorption, which is crucial for the pharmaceutical industry. His work has implications for improving drug formulation and efficacy.
Collaborations
Gibiansky has collaborated with notable colleagues, including David Young and William R Gillespie. These partnerships have contributed to the development and validation of his innovative modeling techniques.
Conclusion
Leonid V Gibiansky's contributions to biological modeling through his patent demonstrate his commitment to advancing the field of pharmacology. His work not only enhances the understanding of drug absorption but also paves the way for future innovations in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile